Going forward..., page-424

With one more day to go before 2018 is over, lets just have a look back where we were at 1 year ago:



Despite knowing that the cohort A day 28 day reading was due out soon, many thought we were dead in the water...

Now, 12 months later (December only):

H.C. Wainwright & Co


http://files.cynata.com/445/Cynata-Therapeutics-(CYP-AU)_14Dec18-Update.pdf

CommSec



nab trade



And even good ol’ Tim Boreham listed us in his article in the Australian yesterday

“Best investment ideas for 2019

[...]

Stem-cell play (19) Cynata Therapeutics (CYP) in August produced impressive early-stage results for its graft-versus-host disease treatment Cymerus, but the stock has lost about 25 per cent of its value since then.

[...]”
www.theaustralian.com.au/business/wealth/best-investment-ideas-for-2019/news-story/b36267aa898f30bc59aa11643611dcf3

As @ZolRab said, that is based on things we now, excluding any unexpected surprises.

And there are plenty of reasons why 2019 could become the year of the left field for Cynata

Enjoy your Year-end celebration tomorrow and I’ll see you all in the New Year!!